Oliver Armfield
Allergy Therapeutics (United Kingdom)(GB)
Publications by Year
Research Areas
Allergic Rhinitis and Sensitization, Dermatology and Skin Diseases, Food Allergy and Anaphylaxis Research, Asthma and respiratory diseases, Ocular Surface and Contact Lens
Most-Cited Works
- → Peripheral blood mononuclear cell transcriptome profile in a clinical trial with subcutaneous, grass pollen allergoid immunotherapy(2024)6 cited
- → The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence‐Based Approach(2025)1 cited
- → Modulation of Cellular, Molecular, and Humoral Responses by PQ Grass 27,600 SU for the Treatment of Seasonal Allergic Rhinitis: A Randomised Double Blind Placebo Control Exploratory Field Study(2025)1 cited
- → Clinical Trial Experience With a New Pollen Sampling Network In The US(2022)
- → Differential Transcriptome Immunomodulatory Profile of an Adjuvanted Modified Grass Immunotherapy in Subjects with Seasonal Allergic Rhinitis and Rhinoconjuctivitis(2023)
- → Modulation of Pro-Allergic T Cell Responses by PQ Grass 27600 SU as a Treatment for Seasonal Allergic Rhinitis: A RDBPC Pilot Study(2023)
- → Induction of Local and Systemic Blocking Antibodies by PQ Grass 27600 SU for the Treatment of Seasonal Allergic Rhinitis: A RDBPC Pilot Study(2023)
- → Title of Article: Response to Correspondence ALL-2023-01107 “Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy”(2024)
- → Response to Correspondence ALL-2023-01107 “Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy”(2024)